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Predictionmodels should be externally validated before being used in clinical practice. Many published prediction
models have never been validated. Uncollected predictor variables in otherwise suitable validation cohorts are the
main factor precluding external validation. We used individual patient data from 9 different cohort studies conducted
in the United States, Europe, and Latin America that included 7,892 patients with chronic obstructive pulmonary
disease who enrolled between 1981 and 2006. Data on 3-year mortality and the predictors of age, dyspnea, and
airflow obstruction were available. We simulated missing data by omitting the predictor dyspnea cohort-wide, and
we present 6 methods for handling the missing variable. We assessed model performance with regard to discrim-
inative ability and calibration and by using 2 vignette scenarios. We showed that the use of any imputation method
outperforms the omission of the cohort from the validation, which is a commonly used approach. Compared with
using the full data set without the missing variable (benchmark), multiple imputation with fixed or random intercepts
for cohorts was the best approach to impute the systematically missing predictor. Findings of this studymay facilitate
the use of cohort studies that do not include all predictors and pave the way for more widespread external validation
of prediction models even if 1 or more predictors of the model are systematically missing.
COPD; decision support techniques; logistic models; meta-analysis; missing data; validation studies
Abbreviations: AUC, areaunder the receiver operating characteristic curve;COPD, chronic obstructive pulmonary disease; FEV1, forced
expiratory volume in 1 second; IPD, individual patient data; MRC, Medical Research Council; PLATINO, Proyecto Latinoamericano
de Investigación en Obstrucción Pulmonar; SEPOC, Quality of Life of Chronic Obstructive Pulmonary Disease Study.
A common barrier to the use or validation of existing
prediction models in populations that are different from the
populations in which the model was developed is the unavail-
ability of 1 or more predictors in the external data set. For
example, the regression model underlying the BODE index
(so named because it incorporates bodymass index, airﬂow ob-
struction, dyspnea, and exercise capacity) to predict mortality in
patients with chronic obstructive pulmonary disease (COPD)
was not externally validated until data on all predictors (includ-
ing 6-minutewalk distance), as well as outcome, were available
from cohort studies from Spain (Phenotype and Course of
COPD) and Switzerland (Barmelweid cohort) (1).
Missing data are a serious problem in the veriﬁcation of
prediction models and are a known source of biased results
(2). The problem exists when data are missing for individual
patients or when predictor data have not been collected in a
cohort at all. A simple, but not recommended, approach to
handling missing data is to exclude the incomplete patient re-
cord, or (in the case of a systematically missing predictor) the
entire cohort, from the analysis. Doing so does not address
the mechanism that generated the missing data. In a recent re-
view of methodological conduct of validation studies of pre-
diction models, Collins et al. (3) found that inappropriate
handling and acknowledgment of missing predictor data
from individuals is a common problem in validation studies.
A substantial body of literature about imputation techniques
for analyses using single and multiple studies emerged re-
cently (4–7). If predictors have not been collected at all—if
1
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data for a speciﬁc predictor are missing entirely—the prob-
lem is even greater. Ahmed et al. (8) demonstrated that uncol-
lected predictors often lead to the omission of entire studies
within individual patient data (IPD) meta-analysis. Resche-
Rigon et al. (9) addressed the problem of cohort-wide miss-
ing variables with a random-effects Cox model for multiple
imputation. The use of random-effects models in multiple
imputation is rather uncommon, as a recent review by
Ahmed et al. (8) showed; they found that in 10 of 15 IPD
meta-analyses, the authors ignored the clustering of patients
within studies, and in 3 studies, the authors accounted for
clustering by including ﬁxed study effects. Jolani et al. (10)
addressed the problem of systematically missing predictors
by including random effects for predictor variables to allow
for between-study heterogeneity. The aim of this paper is to
explore how systematically missing predictors could be im-
puted, and how the model’s predictive performance changes
depending on different imputation methods as well as cohort-
speciﬁc characteristics.
Based on an approach by Puhan et al. (11), IPD information
on age, dyspnea, and forced expiratory volume in 1 second
(FEV1) (the components of theADO index) of COPDpatients,
as well as 3-year mortality rate and sex, was gathered from 9
cohorts, including the Barmelweid cohort (Switzerland) (1),
Basque study (Spain) (12) , Copenhagen City Heart Study
(Denmark) (13), Cardiovascular Health Study (United States)
(14), Jackson Heart Study (United States) (15), National Em-
physema Treatment Trial (United States) (16), Phenotype and
Course of COPD (Spain) (17), Proyecto Latinoamericano de
Investigación en Obstrucción Pulmonar (PLATINO) (South
America) (18), and Quality of Life of Chronic Obstructive Pul-
monary Disease Study (SEPOC) (Spain) (19).We derived and
compared several methods for handling a systematically miss-
ing predictor using the full data set as the benchmark. We hy-
pothesized that if variables of the prediction model were
missing entirely in some cohorts, some form of imputation
would preserve the predictive accuracy of the model better
than elimination of the entire cohort would.
METHODS
The original data pool for this analysis consisted of 9 co-
hort studies that included 7,892 patients without any missing
information for the variables of age, modiﬁed Medical Re-
search Council (MRC) dyspnea scale grade, percent predicted
FEV1, and survival status within 3 years. We selected the
modiﬁed MRC dyspnea scale as the predictor to be excluded.
The modiﬁedMRC dyspnea scale has 3 grades: 0 or 1, 2 or 3,
and 4. Age was measured continuously in years, and FEV1
was dichotomized into less than or equal to 50% and more
than 50%. Patients with a FEV1 of 50% or lower were consid-
ered to have severe COPD. Our purpose was not to provide
yet another validation of the ADO index, about which we
have published previously (11). Instead, we aimed to address
the methodological question of how to impute entire predic-
tors if they are missing from a cohort’s data. Therefore, we
took the liberty of modifying the data set in order to make
it ﬁt for the purpose of this analysis. Categories of MRC
dyspnea scale grade and FEV1 were introduced because
doing so enhanced the chance of ﬁnding differences between
imputation methods, thereby leaving more room for improve-
ment compared with the continuous versions of the predic-
tors. The cohorts were divided into 2 categories according to
setting: specialized pulmonary medicine setting (Barmelweid,
National Emphysema Treatment Trial, and SEPOC) and pri-
mary care/nonspecialized care setting (Basque study, Copenha-
gen City Heart Study, Cardiovascular Health Study, Jackson
Heart Study, Phenotype and Course of COPD, and PLATINO),
as described elsewhere (11).
Our benchmark model was a logistic regression model with
random intercepts by study. Speciﬁcally, our model was for-
mulated as η =Xβ +Zu + ε, where η is the logit of 3-year mor-
tality; X is the matrix of predictors that includes a vector of
ones (intercept) and the variables age, setting, MRC dyspnea
scale grade, and FEV1; β is a vector of regression coefﬁcients
associated with the predictors; Z is a matrix of dummy vari-
ables indicating the different studies; u is a vector of study-
speciﬁc random effects, with E(u) = 0 and VarðuÞ ¼ σ2u; and
ε is a vector of residuals with E(ε) = 0 and VarðεÞ ¼ σ2ε.
When using multiple imputation to deal with the missing
data, we set the number of imputations as m = 5 (20) because
the maximum percentage of missing values was below 30%.
To simulate a systematically missing predictor, we left out
MRC dyspnea scale grade cohort-wide.
We then chose 6 different modeling approaches to evaluate
which approach dealt best with the completely missing pre-
dictor. These approaches included reestimation of the model
parameters to measure the inﬂuence of computation tech-
niques rather than model reﬁtting alone. The modeling ap-
proaches are listed in detail below.
1a. Exclude the study and use the study-speciﬁc setting: Fit
the model to include information on specialized/non-
specialized care setting on all available data (n < 7,892).
1b. Exclude the study and use random study effects: Fit the
model with a random study effect on all available data
(n < 7,892).
2. Exclude the predictor: Fit the model without the missing
predictor on all data (n = 7,892).
3. Use mode imputation: Before ﬁtting the model, replace
the MRC dyspnea scale grade in the excluded cohort
with the mode (n = 7,892).
4. Fit a multiple-imputation model for MRC dyspnea scale
grade with ﬁxed study effects: Conduct multiple impu-
tation based on the variables death, age, FEV1, sex, and
study. Model coefﬁcients for prediction included age,
MRC dyspnea scale grade, FEV1, and ﬁxed study ef-
fects (n = 7,892).
5. Fit a multiple-imputation model for MRC dyspnea scale
grade with random study effects: Conduct multiple im-
putation as described above. Model coefﬁcients for pre-
diction included age, MRC dyspnea scale grade, FEV1,
and random study effects (n = 7,892).
We repeated this process 9 times to simulate the situation with
a missing predictor variable for each of the cohorts. The ap-
proaches were compared with respect to different parameters:
We measured the predictive accuracy of the models using the
area under the receiver operating characteristic curve (AUC)
to evaluate discriminative ability. The Wilcoxon test was
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used to evaluate whether there was a signiﬁcant difference
between AUC values across cohorts for different modeling
approaches. Calibration plots were used to show the relation-
ship between model-based predictions of mortality and ob-
served proportions of mortality within prespeciﬁed bins.
The Brier score (21) was assessed as a combination of dis-
crimination and calibration. The Brier score is the mean
squared error for the difference between the predicted proba-
bility of death and the true survival status (0 = alive, 1 =
dead). Models with smaller Brier score values are preferred.
The reference value for the Brier score can be obtained by
using the percentage of patients who died in the study popu-
lation as the individual predicted probability of death.
In addition, we constructed 2 scenarios for which we
predicted individual absolute risks of 3-year mortality based
on the different approaches. One scenario included a 70-year-
old man with COPD, an MRC dyspnea scale grade of 4 (orig-
inal scale), and an FEV1 percent predicted of 50% of less who
came from a specialty care setting. The other scenario included
a 70-year-old woman with COPD, an MRC dyspnea scale
grade of 2 (original scale), and an FEV1 percent predicted
greater than 50% who came from nonspecialty care setting.
We evaluated the predicted probability of death within 3
years for both scenarios and for the different approaches. We
then calculated the percentage changes of these probabilities
compared with the predicted probabilities of the benchmark
model. All analyses were performed with R for Windows (R
Foundation for Statistical Computing, Vienna, Austria) (22)
and the R packages lme4 (23), nlme (24), mi (25), MKmisc
(26), and PresenceAbsence (27).
RESULTS
The size of the cohorts varied from 106 to 2,273 patients,
and the 3-year mortality rate varied from 7% to 34%. The
Table 1. Summary of Number of Patients and 3-Year Mortality Rate
in 9ChronicObstructivePulmonaryDiseaseCohort StudiesConducted
in the United States, Europe, and Latin America, 1981–2006
Cohort No. of Patients No. of Deaths 3-YearMortality, %
BMW 231 79 34
Basque study 106 16 15
CCHS 2,273 184 8
CHS 2,109 169 8
JHS 419 29 7
NETT 1,934 516 27
PAC-COPD 330 39 12
PLATINO 173 16 9
SEPOC 317 61 19
Abbreviations: BMW, Barmelweid cohort; CCHS, Copenhagen City
Heart Study; CHS, Cardiovascular Health Study; COPD, chronic
obstructive pulmonary disease; JHS, Jackson Heart Study; NETT,
National Emphysema Treatment Trial; PAC-COPD, Spanish Phenotype
and Course of COPD; PLATINO, Proyecto Latinoamericano de
Investigación en Obstrucción Pulmonar; SEPOC, Quality of Life of
Chronic Obstructive Pulmonary Disease Study.
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Figure 1. Area under the receiver operating characteristic curve
(AUC) (A) and Brier score (B) for each of the 6 modeling options for
dealing with amissing predictor and with respect to the individual cohort
left out using data from9 cohort studies. Patients whose datawere used
for this analysis were recruited between 1981 and 2006. The dashed
line indicates AUC or Brier score using the full data set (benchmark).
Modeling options 4 and 5 are based onmultiple-imputation techniques.
The excluded numbers of patients per cohort were: Barmelweid cohort,
n = 231 (○); Basque study, n = 106 (Δ); Copenhagen City Heart Study,
n = 2,273 (+); Cardiovascular Health Study, n = 2,109 (×); Jackson
Heart Study, n = 419 (⋄); National Emphysema Treatment Trial, n =
1,934 (▿); Phenotype and Course of Chronic Obstructive Pulmonary
Disease, n = 330 ( );Proyecto Latinoamericano de Investigación en
Obstrucción Pulmonar, n = 173 ( ); and Quality of Life of Chronic Ob-
structive Pulmonary Disease Study, n = 317 ( ). Modeling options
were “exclude study, use study-specific setting” (1a), “exclude study,
use random study effects” (1b), “exclude predictor” (2), “mode imputa-
tion” (3), “multiple imputation with fixed study effects” (4), and “multiple
imputation with random study effects” (5).
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overall 3-year mortality rate was 14%, which resulted in a ref-
erence Brier score of 0.120. Table 1 summarizes the cohort-
speciﬁc 3-year mortality rates. A detailed description of the
included cohorts can be found elsewhere (11).
Web Table 1 (available at http://aje.oxfordjournals.org/)
shows the summary of model performance as measured
using AUC and Brier score, including 95% conﬁdence inter-
vals applied to the full data set and with MRC dyspnea scale
grade set to missing for each of the cohorts separately. Our
benchmark model—a model with all predictors and random
study effects ﬁtted to the full data set—had an AUC of 0.750
(95% conﬁdence interval: 0.735, 0.765) and a Brier score of
0.108 (95% conﬁdence interval: 0.104, 0.113).
Results with respect to AUC and Brier score
A summary of the results with respect to the AUC and
Brier score is presented in Figure 1A and 1B. When compar-
ing the AUCs resulting from the different approaches when 1
cohort had a missing MRC dyspnea scale grade for all pa-
tients, we obtained the lowest AUC (0.732) for the case in
which the predictor MRC dyspnea scale grade was left out
of the model. We obtained the best results with respect to av-
erage AUC across the 9 cohorts with the ﬁxed-effects model
with multiple imputation (AUC between 0.747 and 0.751),
although multiple imputation with random effects performed
almost as well. Imputing the most frequent value resulted in
performance worse than that obtained by excluding the co-
hort with the missing predictor while including a random
study effect. Exclusion of a cohort resulted in much higher
variability of the AUC compared with the multiple-imputation
options, which may be due to the observed variables rather
than deleted variables. We compared the AUC values result-
ing from modeling approach 1a across the 9 cohorts with
those of modeling approach 4 using the Wilcoxon test. The
resulting P value was <0.001, demonstrating that multiple
imputation with ﬁxed study effects resulted in signiﬁcantly
higher AUC values.
The cohorts from the Copenhagen City Heart Study, Na-
tional EmphysemaTreatment Trial, and Cardiovascular Health
Study each includedmore than 1,900 patients.When 1 of these
cohorts was left out, the resulting AUC values were relatively
small for modeling options 1a, 1b, and 3. When multiple im-
putation was used with ﬁxed or random study effects (model-
ing approaches 4 and 5), the AUC values were much closer to
those achieved when small cohorts were left out, indicating
that this approach is superior especially when the number of
missing values is large.
With respect to the Brier score, we again found that the
model in which we left out the entire predictor had the largest
Brier score (0.111; 95% conﬁdence interval: 0.106, 0.116),
and we obtained lowest Brier scores with ﬁxed or random
study effects (values ranging from 0.107 to 0.109 over all co-
horts excluded).
Figure 2 presents the calibration of the benchmark model
ﬁtted to the full data set and with the model leaving out
MRC dyspnea scale grade (modeling approach 2) as a pre-
dictor. Figure 2A shows that the benchmark model was very
well calibrated. Only in the highest bin did the predicted
probabilities overestimate the true proportion of deaths.
For the model in which the missing predictor was left out
(Figure 2B), calibration was fairly good, but in the highest
bin, the predicted probabilities underestimated the true pro-
portion of deaths.
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Figure 2. Calibration plots of the benchmark model (A) and the model without the predictor Medical Research Council dyspnea scale grade (B) in
9 cohort studies, 1981–2006. The Figure shows grouping of the predicted versus observed data in 0.1-step bins. The included cohorts were the
Barmelweid cohort, Basque study, Copenhagen City Heart Study, Cardiovascular Health Study, Jackson Heart Study, National Emphysema Treat-
ment Trial, Phenotype and Course of Chronic Obstructive Pulmonary Disease, Proyecto Latinoamericano de Investigación en Obstrucción Pulmo-
nar, and Quality of Life of Chronic Obstructive Pulmonary Disease Study. Bars, 95% confidence intervals.
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Scenarios
As described above, we chose 2 common scenarios of patient
characteristics. The predicted 3-year mortality rate for each of
the approaches is displayed in Table 2. For these 2 scenarios,
the imputation methods using either ﬁxed study effects (model-
ing approach 4) or random study effects (modeling approach 5)
resulted in predicted 3-year mortality probabilities that were
very close to those obtained when the full data pool was in-
cluded. Again, when the missing predictor was left out, the
probability of death was underestimated. These results corre-
spond to those from the calibration plots shown in the Figures.
DISCUSSION
In the present study, our aim was to explore how systemati-
cally missing predictors could be imputed and to evaluate
how the model’s predictive performance changes depending
on imputation techniques and cohort-speciﬁc characteristics
in an IPD meta-analysis. We used data from 9 cohorts com-
prising participants with COPD that had sample sizes that
varied from 106 to 2,273 patients. We set predictor variables
to missing cohort-wide, sequentially over each of the 9 co-
horts included. We found that eliminating the cohort with
the missing predictor (modeling approaches 1a and 1b) led
to high variability in discriminative ability and calibration
(as expressed in AUC and Brier score). When the variables
used with the cohort that was omitted differed substantially
from those used with the other cohorts, the AUC was overes-
timated and the Brier score was underestimated compared
with the benchmark AUC and Brier score. When the predic-
tor was eliminated from the model (modeling approach 2),
the discriminative ability was the smallest and the Brier
score was largest.
We used different approaches to deal with the missing pre-
dictor cohort-wide. The simple approach of mode imputation
(modeling approach 3) outperformed (on average) the elimi-
nation of cohorts with information on specialized/nonspe-
cialized care setting (approach 1a) or predictors (approach
2). More advanced approaches based on multiple imputation
of the missing data with ﬁxed (modeling approach 4) or ran-
dom (modeling approach 5) study effects gave results very
close to those from the benchmark model, in which all pre-
dictor variables were available in all cohorts. Results of the
multiple-imputation approaches also had largest average
AUCs, as well as the smallest variability across excluded co-
horts. When large cohorts (more than 1,900 patients) were
excluded, the simple approaches resulted in low AUC values,
whereas the AUCs based on multiple-imputation approaches
with ﬁxed or random study effects were much less affected by
sample size. Similar results can be seen with respect to the
Brier score: The variability is very large for the scenarios
in which cohorts are left out (modeling approaches 1a and
1b), whereas variability and bias were lowest when using
the multiple-imputation approaches (approaches 4 and 5).
We concluded that excluding cohorts leads to higher variabil-
ity in AUC and Brier score than using imputation methods,
and the variability in model performance can be substantial
depending on the characteristics of the excluded cohort.
Any prediction model developed in a particular population
needs critical evaluation of its performance in other popula-
tions. For some prediction models, such as models to predict
cardiovascular events, there are many cohort studies in which
all of the predictors are available (28). However, many pub-
lished prediction models are never reevaluated (8), with one
of the reasons being the unavailability of 1 or more predictors.
For example, Steyerberg (29) described a model for the pre-
diction of abdominal aneurysmmortality that was validated in
2 studies, 1 in the United Kingdom and 1 in the Netherlands.
In the UK validation study, 2 predictors were missing,
whereas in the Dutch validation study of the same model,
only 1 predictor wasmissing. In theDutch study, investigators
found much better performance than did those in the UK
study, indicating that leaving out a predictor may result in un-
derestimation of a model’s predictive performance. In a recent
paper by Siddique et al. (30), the authors addressed the prob-
lem of outcome variables of interest (depression measures) in
an IPD meta-analysis being measured in different ways. They
considered the situation as a missing-data problem and used a
Bayesian approach to multiply impute the missing outcome
information while taking into account the relationship be-
tween the measures from calibration studies.
In a recent paper by Collins et al. (3), the authors addressed
the conduct in and reporting of external validation studies and
found that the vast majority of studies were lacking with re-
spect to reporting, design, and handling of missing data. In a
Table 2. Predicted 3-Year Mortality in 2 Scenarios Using a Selection
of Modeling Approaches, 9 Chronic Obstructive Pulmonary Disease
Cohort Studies Conducted in the United States, Europe, and Latin
America, 1981–2006
Scenario and Model Predicted3-Year Mortality
Deviation
(% Points)
Scenario 1a
Benchmark 0.36
1ab 0.40 4
2c 0.26 −10
4d 0.39 3
5e 0.38 2
Scenario 2f
Benchmark 0.12
1ab 0.10 −2
2c 0.10 −2
4d 0.13 1
5e 0.13 1
a Male patient who was 70 years of age with a Medical Research
Council dyspnea scale grade of 4 and forced expiratory volume in
1 second ≤50% from the Quality of Life of Chronic Obstructive
Pulmonary Disease Study cohort.
b Cohort left out; reduced data set.
c Full data set without the predictor Medical Research Council
dyspnea scale grade.
d Full data set; multiple imputation with fixed study effects.
e Full data set; multiple imputation with random study effects.
f Female patient whowas 70 years of agewith a Medical Research
Council dyspnea scale grade of 2 and forced expiratory volume in
1 second >50% from the Copenhagen City Heart Study cohort.
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case in which a single cohort with a missing predictor is
available, we propose incorporating the study setting into
the intercept and using multiple imputation. If more than 1
cohort is available, multiple imputation with ﬁxed or random
study effects is the best way to comprehensively reevaluate
prediction models. Our approach can also be combined with
multiple imputation of partially missing data. If a small per-
centage of values is missing for individual patients, these
can be imputed together with the missing predictor. Two-stage
multiple imputation (31) may also be used. In the ﬁrst step,
partially missing data are imputed for each cohort; imputation
of the entire predictor then follows when necessary.
To our knowledge, the present study is the ﬁrst in which
researchers have addressed the question of model perfor-
mance as measured with discriminative ability and calibra-
tion when leaving out cohorts or using different imputation
techniques for cohort-wide missing predictors in a logistic re-
gression setting. We had 9 cohorts with COPD patients that
contained all 3 predictors of a published prediction model for
3-year mortality (1), as well as the outcome. We left out the
modiﬁed MRC dyspnea scale grade across these cohorts and
used 6 different methods for handling the cohort-wide miss-
ing data. Across the different cohorts, we evaluated model
performance for the different modeling approaches, and we
compared the ﬁndings with the reference categories in
which no data were missing (benchmark).
Two of the 6 modeling approaches reﬂected a poorly per-
forming but common approach in practice: omitting the co-
hort with the missing predictor. In 1 of these approaches,
information on specialized/nonspecialized care setting was
included; in the other approach, random study effects were
included. The general design of the present study may be
used to further explore imputationmethods in predictionmod-
els that contain more predictors or predictors with other func-
tional forms (e.g., continuous or transformed data). In our
study, the multiple-imputation model for the MRC dyspnea
scale grade predictor included the variables of death, age,
FEV1, sex, and study. This set of variables is not speciﬁcally
and closely related to themissing predictor, but it does contain
a variable outside of the prediction model (sex). The potential
of multiple-imputation approaches for making a validation co-
hort suitable for the predictive model of interest could be even
larger if different but similar variables need to be imputed.
This could, for example, include a biomarker measured in
blood samples as opposed to urine samples.
Our study has several strengths and limitations. Strengths
of our study include the number and diversity of cohorts in
terms of sample size, setting, disease severity, and outcome
frequency (disease mix), which allowed us to evaluate the
consistency of a particular imputation technique. Also, we
used different measures for model performance, including
AUC, Brier score, and calibration plots. For multiple imputa-
tion, we chosem = 5 imputations, butm = 3 could also be suf-
ﬁcient if less than 20% of data are missing (20, 32). In more
recent papers, it has been suggested that the number of impu-
tations should be higher with higher percentages of missing
values (33). Across the cohorts we analyzed, the percentage
of missing values ranged from 1.3% to 28.8%.
Our study has several limitations. We focused on a single
prediction model with just 3 predictors and 3-year mortality
rate as the outcome in patients with COPD. This scenario rep-
resents a relatively simple case and calls for extension to other
disease areas, types and numbers of missing predictors, and
outcomes. Because the outcome variable in our study was bi-
nary, we focused on logistic regression approaches. Other ap-
proaches include classiﬁcation trees or neural networks (34),
which also have high discriminative power. However, the ad-
vantage of logistic regression models is that estimated coefﬁ-
cients can be interpreted easily from a clinical perspective
(35). In the present study, we focused on missing data for a
single predictor that was missing cohort-wide. It is straight-
forward to generalize the approach to missing predictors in
more than 1 cohort or to missing observations for other var-
iables in the prediction model.
In summary, we explored different methods to impute an
uncollected variable for validation of a prediction model. We
found that multiple imputation with ﬁxed or random study ef-
fects is the best approach to impute values for a predictor for
thewhole cohort. These approaches consistently outperformed
other methods across data sets and metrics for model perfor-
mance. Results of this study may facilitate the use of cohort
studies that do not include all predictors and pave the way
for more widespread validation of prediction models.
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